Finland· FI-REL-REL56140
Dovato
A lamivudine and dolutegravir product containing dolutegravir sodium + lamivudine, registered in Finland by Orifarm Oy. The same ATC class is registered in 13 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Lamivudine and dolutegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR25 (lamivudine and dolutegravir), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Lamivudine and dolutegravir · ATC J05AR25
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Dolutegravir sodium + Lamivudine
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- J05AR25
- ATC class
- Lamivudine and dolutegravir
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lamivudine and dolutegravir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDOVATOViiV Healthcare BV, Amersfoort
- SpainDOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULAViiv Healthcare B.V.
- SwitzerlandDovato
- IcelandDOVATOViiV Healthcare BV
- NetherlandsDovato 50 mg/300 mg filmomhulde tablettenViiV healthcare B.V.
- NorwayDovatoViiV Healthcare BV (1)
- PolandDovatoViiV Healthcare BV
- SwedenDOVATO 50 mg/300 mg Filmdragerad tablettViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Dovato
- Liechtenstein · Dovato
- Norway · Dovato
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/903e4385-8310-4be0-bc7e-1168da9db192 GET /v1/drugs/903e4385-8310-4be0-bc7e-1168da9db192?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "50 mg / 300 mg",
"atc_label": "lamivudiini ja dolutegraviiri",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/19/1370/01",
"fimea_rel_id": "REL56140",
"authorised_at": "2020-02-05"
}See everything about lamivudine and dolutegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.